Optimizing Patient Selection & Stratification to Improve Success in Clinical Trials
- What should the patient cohort selection look like to give best chance of success?
- Which clinical end points to be selected to assess anti-tumor efficacy?
- How can the late stage product manufacturing process look like for neoantigen programs?